Udayavni Special

Lupin launches COVID-19 drug Favipiravir in India at Rs 49 per tablet


PTI, Aug 5, 2020, 12:24 PM IST

New Delhi: Drug major Lupin on Wednesday, August 5 announced the launch of its Favipiravir drug under the brand name ‘Covihalt’ for the treatment patients with mild to moderate COVID-19 symptoms at Rs 49 per tablet in India.

Favipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filing.

Its Covihalt dosage strength has been developed keeping in mind convenience of administration, it stated, adding that the drug is available as 200 mg tablets in the form of a strip of 10 tablets, and priced at Rs 49 per tablet.

Lupin President – India Region Formulations (IRF) Rajeev Sibal said the company believes that it can leverage its expertise in managing widespread community diseases like tuberculosis to proacti

vely reach patients across India and ensure access to Covihalt through its strong distribution network and field force.

On August 4, Sun Pharmaceutical Industries had launched Favipiravir under the brand name ”FluGuard” for the treatment of mild to moderate cases of COVID-19, at Rs 35 per tablet in India.

Shares of Lupin were trading 0.32 per cent higher at Rs 943.70 apiece on BSE.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

India might see ‘serious livelihood crisis’, says economist Jean Dreze

1971 war veteran Sqn Ldr Anil Bhalla (Retd) no more

Prioritise vaccinating those due for second dose of COVID-19 vaccine: Centre to states

Over-staying COVID-19 patients in hospitals should go home, says BSY

Telangana announces 10-day lockdown from May 12

Met Dept forecasts thunderstorm in Udupi, DK and Kodagu dists on Monday evening

‘Variant of Concern’: All you need to know about the Indian variant of Covid-19



Related Articles More

Active COVID cases down by over 30,000 in 24 hours first time in 61 days: Health ministry

Prepare for the third wave of COVID-19: BSY to officials

Indian Covid strain ‘variant of concern’: WHO

M’luru, Udupi: COVID-19 death toll rises in DK; Udupi sees decrease in infections

Reports state China probed weaponising SARS‑CoV‑2 viruses in 2015

MUST WATCH

Udayavani 11 -May -2021 News Bulletin

Karnataka’s first oxygen express to reach Whitefield

Kuwait ship carrying medical oxygen arrives at Navamangalore port

Dr Dinesh Shetty | Current Situation in Karnataka | Udayavani

Young man comes to buy vegetables wearing doctor’s apron

Latest Additions

India might see ‘serious livelihood crisis’, says economist Jean Dreze

1971 war veteran Sqn Ldr Anil Bhalla (Retd) no more

Prioritise vaccinating those due for second dose of COVID-19 vaccine: Centre to states

Centre, states doing everything possible to tackle COVID crisis: Rajnath

Govt says no link between 5G and spread of COVID, urges public to not fall for baseless claims

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.